| Symbol | CGON |
|---|---|
| Name | CG ONCOLOGY, INC. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | Biological Products, (No Diagnostic Substances) |
| Address | 400 SPECTRUM CENTER DRIVE,SUITE 2040, ¿IRVINE, California, 92618, United States |
| Telephone | (949) 409-3700 |
| Fax | — |
| — | |
| Website | https://www.cgoncology.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | — |
| Description | CG Oncology is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. We see a world where urologic cancer patients can benefit from our innovative immunotherapies to live with dignity and have an enhanced quality of life. Additional info from NASDAQ: |
New Form DEFA14A - CG Oncology, Inc. <b>Filed:</b> 2026-04-24 <b>AccNo:</b> 0001193125-26-177424 <b>Size:</b> 1 MB
Read moreMulay James 🟡 adjusted position in 15.6K shares (1 derivative) of CG Oncology, Inc. (CGON) at $73.01 ($2.3M) Transaction Date: Apr 17, 2026 | Filing ID: 164013
Read more📋 JAMES MULE (Director) plans to sell 18K shares of CG Oncology, Inc. (at $66.34 each, total $1.2M) Filed: Apr 17, 2026 | ID: 003597
Read moreKasturi Vijay 🟢 acquired 79.2K shares (1 derivative) of CG Oncology, Inc. (CGON) at $67.68 ($5.4M) Transaction Date: Apr 15, 2026 | Filing ID: 159030
Read morePatterson Joshua F. 🟢 acquired 45.3K shares (1 derivative) of CG Oncology, Inc. (CGON) at $67.68 ($3.1M) Transaction Date: Apr 15, 2026 | Filing ID: 159029
Read moreDETORE JAMES M. 🟢 acquired 90.6K shares (1 derivative) of CG Oncology, Inc. (CGON) at $67.68 ($6.1M) Transaction Date: Apr 15, 2026 | Filing ID: 159025
Read moreKuan Arthur 🟢 acquired 271.6K shares (1 derivative) of CG Oncology, Inc. (CGON) at $67.68 ($18.4M) Transaction Date: Apr 15, 2026 | Filing ID: 159024
Read moreNew Form SCHEDULE 13G/A - CG Oncology, Inc. <b>Filed:</b> 2026-03-26 <b>AccNo:</b> 0000102909-26-000918 <b>Size:</b> 7 KB
Read moreMulay James 🟡 adjusted position in 2.0K shares (2 derivative) of CG Oncology, Inc. (CGON) at $63.50 Transaction Date: Mar 16, 2026 | Filing ID: 110831
Read more